Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02488408
Title	Multicenter Open-label Study of BGB324 as a Single Agent and in Combination With Cytarabine in Patients With AML
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	BerGenBio AS
Indications	acute myeloid leukemia
Therapies	Cytarabine Bemcentinib
Age Groups:	adult
Covered Countries	USA \| NOR \| ITA \| DEU

Filter rows:

Showing 1 to 12 of 12 entries

Facility	City	State	Zip	Country	Details
Azienda Ospedaliera S Croce E Carle, Via Michele Coppino	Cuneo		12100	Italy	Details
Azienda Ospedaliero-Universitaria di Parma	Parma		43126	Italy	Details
Frankfurt Medizinische Klinik II, Hämatologie/Onkologie, Haus 33, 2. OG	Frankfurt	Theodor-Stern-Kai	60590	Germany	Details
Medizinische Hochschule Hannover,Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation,	Hannover	Carl-Neuberg-Str	30625	Germany	Details
Ospedale Lecce - 'V Fazzi' U. O. Ematologia - P. O. Vito Fazz Piazza Muratore, IV piano Polo Oncologico	Lecce		73100	Italy	Details
Ospedale Policlinico San Martino	Genoa		16132	Italy	Details
Studienzentrale der Hämatologie/Onkologie III, Medizinische Klinik	Mannheim			Germany	Details
The University of Texas M.D. Anderson Cancer Center	Houston	Texas	77030	United States	Details
University Medical Center Hamburg	Hamburg	Hamburg-Eppendorf	20246	Germany	Details
University of Bergen Department of Clinical Science, Translational Hemato-Oncology group, Faculty of Medicine and Dentistry, Haukelands University Hospital	Bergen	Jonas Lies Vei	5021	Norway	Details
University of Iowa Hospitals and Clinics	Iowa City	Iowa	52242	United States	Details
Universitätsklinikum Ulm	Ulm		89081	Germany	Details

Showing 1 to 12 of 12 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field